GENE ONLINE|News &
Opinion
Blog

2017-11-07|

November 8, 2012: Completion of the Liver Cancer Genome

by GeneOnline
Share To

Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide. The whole genome sequence of HCC was completed by RIKEN, a Japanese research institution, and was published on November 8, 2012. The result revealed many new cancer-associated genes, a variety of genomic alterations, and the common integration sites for hepatitis B virus (HBV) genome. The report was a step forward for studying the HBV virus and for developing new drugs for liver cancer.

Reference

https://www.ncbi.nlm.nih.gov/pubmed/23142287

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
The FDA Expands Use for Gilead Science’s HBV Treatment
2022-11-02
M&A
Xbiome Acquires Ulcerative Colitis Program from Assembly Biosciences
2022-04-29
R&D
Shionogi, NEC Team Up on Hepatitis B Vaccine
2022-04-20
LATEST
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
Join Us for the SABPA OC/LA 16th Annual Biomedical Forum!
2024-04-16
Sequencing Revolution Spotlights the Titans of NGS Innovation
2024-04-16
Oncology’s New Drugs on the Horizon (II): Radiotherapy, Radioligands & Other Therapeutic Agents
2024-04-12
Oncology’s New Drugs on the Horizon (I): Cancer Immunotherapy and Targeted Therapy
2024-04-12
EVENT
2024-04-20
16th SABPA OC/LA Annual Biomedical Forum
The Beckman Center, 100 Academy, Irvine, CA, 92617
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top